Europe Exosome Therapeutics Market

Europe Exosome Therapeutics Market size was valued at USD 22.5 million in 2025 and is forecast to grow from USD 26.1 million in 2026 to reach USD 55.5 million by 2031, at a CAGR of 19.8%.

Description

The Europe Exosome Therapeutics Market size was valued at USD 22.5 million in 2025 and is forecast to grow from USD 26.1 million in 2026 to reach USD 55.5 million by 2031, at a CAGR of 19.8%. Exosome therapeutics leverage naturally secreted extracellular vesicles for targeted drug delivery and regenerative medicine, offering a transformative treatment modality for oncology, neurodegenerative, cardiovascular, and inflammatory disorders. The market sits at the intersection of regenerative medicine, precision biologics, and advanced-therapy-medicinal-product innovation, making it one of the most closely watched emerging technologies across the regional biotechnology and precision-medicine value chain.

Demand for exosome therapeutic platforms remains anchored by growing research activity and clinical trials exploring exosome-based therapies, favorable academic-industry collaborations, and increasing investment in precision medicine across Germany, the United Kingdom, France, and Switzerland. Beyond oncology, exosome therapeutics continue to enable applications in neurodegenerative-disease treatment, cardiovascular repair, and inflammatory-disorder management that require precise, cell-free biological delivery mechanisms. Rising biopharmaceutical R&D expenditure, strong regulatory support for advanced biologics under the EU Advanced Therapy Medicinal Product framework, and continued advances in exosome-engineering technology are sustaining consumption even as the region transitions from early-stage research toward first-in-human clinical translation.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • Europe Exosome Therapeutics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Type (Natural Exosomes, Engineered Exosomes)

      2. By Application (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Inflammatory Diseases, Others)

      3. By End User (Hospitals & Clinics, Research & Academic Institutes, Biopharmaceutical Companies, Others)

      4. By Country

      5. By Company (2025)

    3. Product Map

  • Germany Exosome Therapeutics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Type

      2. By Application

      3. By End User

  • United Kingdom Exosome Therapeutics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Type

      2. By Application

      3. By End User

  • France Exosome Therapeutics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Type

      2. By Application

      3. By End User

  • Switzerland Exosome Therapeutics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Type

      2. By Application

      3. By End User

  • Rest of Europe Exosome Therapeutics Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Type

      2. By Application

      3. By End User

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • Europe Exosome Therapeutics Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. Evox Therapeutics Ltd.

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. Anjarium Biosciences AG

    3. Exo Biologics SA

    4. Capricor Therapeutics, Inc.

    5. Aegle Therapeutics Corp.

    6. PL BioScience GmbH

    7. Kimera Labs, Inc.

    8. Ilias Biologics Inc.

    9. Direct Biologics, LLC

    10. NanoSomiX, Inc.

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology